Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 69,579
Sort by:

Serine-Threonine Protein Kinase-Endoribonuclease IRE1 (Endoplasmic Reticulum To Nucleus Signaling 1 or Inositol Requiring Protein 1 or Ire1 Alpha or Endoribonuclease or ERN1 or EC 2.7.11.1 or EC 3.1.26.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serine-Threonine Protein Kinase-Endoribonuclease IRE1 (Endoplasmic Reticulum To Nucleus Signaling 1 or Inositol Requiring Protein 1 or Ire1 Alpha or Endoribonuclease or ERN1 or EC 2.7.11.1 or EC 3.1.2...

May 2022 38 pages

Serine-Threonine Protein Kinase Pim (Pim Kinase or PIM or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serine-Threonine Protein Kinase Pim (Pim Kinase or PIM or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Serine/Threonine P...

May 2022 55 pages

Serine-Threonine Protein Kinase SIK2 (Qin Induced Kinase or Salt Inducible Kinase 2 or Serine-Threonine Protein Kinase SNF1 Like Kinase 2 or SIK2 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serine-Threonine Protein Kinase SIK2 (Qin Induced Kinase or Salt Inducible Kinase 2 or Serine-Threonine Protein Kinase SNF1 Like Kinase 2 or SIK2 or EC 2.7.11.1) Drugs in Development by Therapy Areas...

May 2022 38 pages

Serine-Threonine Protein Kinase SIK3 (Salt Inducible Kinase 3 or Serine-Threonine Protein Kinase QSK or SIK3 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serine-Threonine Protein Kinase SIK3 (Salt Inducible Kinase 3 or Serine-Threonine Protein Kinase QSK or SIK3 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Mo...

May 2022 37 pages

Serum Albumin (ALB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Serum Albumin (ALB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Serum Albumin (ALB) Drugs in Development by Therapy Areas and Indicat...

May 2022 36 pages

Severe Combined Immune Deficiency (SCID) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Severe Combined Immune Deficiency (SCID) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Severe Combined Immune Deficiency (SCID) Drugs in Development by Stages...

May 2022 51 pages

Sezary Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Sezary Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Sezary Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 57 pages

Short Transient Receptor Potential Channel 5 (Transient Receptor Protein 5 or TRPC5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Short Transient Receptor Potential Channel 5 (Transient Receptor Protein 5 or TRPC5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Shor...

May 2022 37 pages

Signal Transducer And Activator Of Transcription 3 (Acute Phase Response Factor or DNA Binding Protein APRF or STAT3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Signal Transducer And Activator Of Transcription 3 (Acute Phase Response Factor or DNA Binding Protein APRF or STAT3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule...

May 2022 95 pages

Signal Transducer And Activator Of Transcription 5 (STAT5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Signal Transducer And Activator Of Transcription 5 (STAT5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Signal Transducer And Activato...

May 2022 37 pages

Simplexvirus (HSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Simplexvirus (HSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Simplexvirus (HSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 113 pages

Sirtuin (SIRT or EC 2.3.1.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sirtuin (SIRT or EC 2.3.1.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Sirtuin (SIRT or EC 2.3.1.) Drugs in Development by Therapy A...

May 2022 69 pages

Skin Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Skin Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Skin Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 44 pages

Skin And Skin Structure Infections (SSSI) Caused By Bacteria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Skin And Skin Structure Infections (SSSI) Caused By Bacteria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Skin And Skin Structure Infections (SSSI) Caused By...

May 2022 56 pages

Skin And Skin Structure Infections (SSSI) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Skin And Skin Structure Infections (SSSI) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Skin And Skin Structure Infections (SSSI) Drugs in Development by Stag...

May 2022 65 pages

Skin And Soft Tissue Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Skin And Soft Tissue Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Skin And Soft Tissue Infections Drugs in Development by Stages, Target, MoA, RoA...

May 2022 43 pages

Skin Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Skin Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Skin Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 47 pages

Sleep Apnea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Sleep Apnea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Sleep Apnea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 60 pages

Sleep Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sleep Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Sleep Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 135 pages

Small Intestine Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Small Intestine Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Small Intestine Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 46 pages

Smoking Cessation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Smoking Cessation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Smoking Cessation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 53 pages

Social Anxiety Disorder (SAD-Social Phobia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Social Anxiety Disorder (SAD-Social Phobia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Social Anxiety Disorder (SAD/Social Phobia) Drugs in Development by...

May 2022 39 pages

Sodium Channel Protein Type 8 Subunit Alpha (Voltage Gated Sodium Channel Subunit Alpha Nav1.6 or SCN8A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sodium Channel Protein Type 8 Subunit Alpha (Voltage Gated Sodium Channel Subunit Alpha Nav1.6 or SCN8A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 52 pages

Sodium Dependent Dopamine Transporter (DA Transporter or DAT or Solute Carrier Family 6 Member 3 or SLC6A3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sodium Dependent Dopamine Transporter (DA Transporter or DAT or Solute Carrier Family 6 Member 3 or SLC6A3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and K...

May 2022 102 pages

Sodium Dependent Serotonin Transporter (5HT Transporter or 5HTT or Solute Carrier Family 6 Member 4 or SLC6A4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sodium Dependent Serotonin Transporter (5HT Transporter or 5HTT or Solute Carrier Family 6 Member 4 or SLC6A4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type an...

May 2022 94 pages

Sodium-Glucose Cotransporter 1 (High Affinity Sodium-Glucose Cotransporter or Solute Carrier Family 5 Member 1 or SGLT1 or SLC5A1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sodium-Glucose Cotransporter 1 (High Affinity Sodium-Glucose Cotransporter or Solute Carrier Family 5 Member 1 or SGLT1 or SLC5A1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, R...

May 2022 45 pages

Sodium-Glucose Cotransporter 2 (Low Affinity Sodium-Glucose Cotransporter or Solute Carrier Family 5 Member 2 or SGLT2 or SLC5A2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sodium-Glucose Cotransporter 2 (Low Affinity Sodium-Glucose Cotransporter or Solute Carrier Family 5 Member 2 or SGLT2 or SLC5A2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, Ro...

May 2022 76 pages

Soft Tissue Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Soft Tissue Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Soft Tissue Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 310 pages

Solute Carrier Family 2 Facilitated Glucose Transporter Member 1 (Glucose Transporter Type 1 Erythrocyte-Brain or GLUT1 or HepG2 Glucose Transporter or SLC2A1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Solute Carrier Family 2 Facilitated Glucose Transporter Member 1 (Glucose Transporter Type 1 Erythrocyte-Brain or GLUT1 or HepG2 Glucose Transporter or SLC2A1) Drugs in Development by Therapy Areas an...

May 2022 40 pages

Somatostatin Receptor Type 2 (SRIF1 or SSTR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Somatostatin Receptor Type 2 (SRIF1 or SSTR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Somatostatin Receptor Type 2 (SRIF1 or SSTR...

May 2022 43 pages

Somatostatin Receptor Type 5 (SSTR5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Somatostatin Receptor Type 5 (SSTR5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Somatostatin Receptor Type 5 (SSTR5) Drugs in Develo...

May 2022 45 pages

Spasmodic Torticollis (Cervical Dystonia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Spasmodic Torticollis (Cervical Dystonia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Spasmodic Torticollis (Cervical Dystonia) Drugs in Development by Stag...

May 2022 36 pages

Sphingosine 1-Phosphate Receptor (S1PR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Sphingosine 1-Phosphate Receptor (S1PR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Sphingosine 1-Phosphate Receptor (S1PR) Drugs in...

May 2022 69 pages

Spinal Cord Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Spinal Cord Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Spinal Cord Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 146 pages

Spinal Stenosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Spinal Stenosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Spinal Stenosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 36 pages

Splenic Marginal Zone B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Splenic Marginal Zone B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Splenic Marginal Zone B-Cell Lymphoma Drugs in Development by Stages, Targ...

May 2022 54 pages

Squalene Monooxygenase (Squalene Epoxidase or SQLE or EC 1.14.14.17) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Squalene Monooxygenase (Squalene Epoxidase or SQLE or EC 1.14.14.17) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Squalene Monooxygena...

May 2022 37 pages

Squamous Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Squamous Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Squamous Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 165 pages

Squamous Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Squamous Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Squamous Non-Small Cell Lung Cancer Drugs in Development by Stages, Target,...

May 2022 148 pages

Squamous Non-Small Cell Lung Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Squamous Non-Small Cell Lung Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Squamous Non-Small Cell Lung Carcinoma Drugs in Development by Stages, Ta...

May 2022 43 pages

Staphylococcal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Staphylococcal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Staphylococcal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 301 pages

Staphylococcus aureus Alpha Hemolysin (Alpha Toxin or hly) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Staphylococcus aureus Alpha Hemolysin (Alpha Toxin or hly) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Staphylococcus aureus Alpha He...

May 2022 38 pages

Staphylococcus Aureus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Staphylococcus Aureus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Staphylococcus Aureus Infections Drugs in Development by Stages, Target, MoA, R...

May 2022 292 pages

Status Epilepticus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Status Epilepticus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Status Epilepticus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 40 pages

Streptococcal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Streptococcal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Streptococcal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 60 pages

Streptococcal Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Streptococcal Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Streptococcal Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 115 pages

Stress Urinary Incontinence Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Stress Urinary Incontinence Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Stress Urinary Incontinence Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 41 pages

Subacute Necrotizing Encephalomyelopathy (Leigh Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Subacute Necrotizing Encephalomyelopathy (Leigh Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Subacute Necrotizing Encephalomyelopathy (Leigh Disease...

May 2022 40 pages

Subarachnoid Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Subarachnoid Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Subarachnoid Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 43 pages

Substance (Drug) Abuse Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Substance (Drug) Abuse Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Substance (Drug) Abuse Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 88 pages

Filters

Search

Categories

836
28
208
156
143
133
127
93
65,439
803
718
772
123

Publishers

179
1
239
158
389
103
444
148
425
3
202
3
6
1,620
487
76
123
208
111
25
212
1,049
378
23
40
68
472
277
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
1,790
60
1,696
8
8,921
2,212
4,495
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
323
8
3
18
58
901
6
89
12
24
15
1,285
227
128
386
3
74
10
119
228
46
474
26
133
4

Regions

92
58
45
43
41
35
31
30
30
29
28
28
28
26
16
16
14
12
12
10
10
10
9
8
8
8
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
790
495
2
2
2
117
194
102
53
23
704
26
136
526
174
623
64,568

Price

Date

Pages

Offers

1
280
1
1